Determination of the Validity of One-Minute Sit-to-Stand Test in Obese and Overweight Children and Adolescents

Sponsor
Istanbul University-Cerrahpasa (Other)
Overall Status
Recruiting
CT.gov ID
NCT05392920
Collaborator
(none)
28
1
3.8
7.3

Study Details

Study Description

Brief Summary

Obese individuals need to be evaluated comprehensively before exercise programs are determined. Determination of exercise intolerance is important for the detection of functional limitations. One minute sit to stand test (1MSTST) can be used as an alternative to cardiopulmonary exercise tests (CPET) or field tests. It is easy to use, quick to apply, valid and reliable, and applicable even in small areas. In addition, it is a simple assessment adequate for children's needs and behaviors and can be easily applied both in the clinic and at home, making it easier to use in children. Studies have shown that 1MSTST is a valid test in chronic obstructive pulmonary disease (COPD), cystic fibrosis, interstitial lung disease, and, healthy children and adolescents. However, no study has been found regarding the validity of its use in obese children and adolescents.The aim of our study is to investigate the validity and reliability of 1MSTST in overweight-obese children and adolescents.

Condition or Disease Intervention/Treatment Phase
  • Other: assessment study

Study Design

Study Type:
Observational
Anticipated Enrollment :
28 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Determination of the Validity of One-Minute Sit-to-Stand Test in Obese and Overweight Children and Adolescents
Anticipated Study Start Date :
Jul 8, 2022
Anticipated Primary Completion Date :
Oct 2, 2022
Anticipated Study Completion Date :
Nov 2, 2022

Arms and Interventions

Arm Intervention/Treatment
Obese children and adolescents

Obese children and adolescent patients

Other: assessment study
there is no intervention in this study

Outcome Measures

Primary Outcome Measures

  1. 1 min sit to stand test [Baseline]

    Only a chair and a stopwatch are needed to apply the test. It is recommended to use a chair with a height of 45-48 cm, preferably against the wall, fixed, without arm support. The patients will sit with their feet flat on the ground and cross their arms over the chest. The patient will be asked to get up from the chair and sit down as fast as he/she can for 1 minute. The number of standing up will be recorded.

  2. 6 minute walk test [Baseline]

    The patient's exercise capacity will be determined by the six minute walk test. The test will be applied in a corridor 30 meters long. The patient will be asked to walk as fast as possible for six minutes. The patient can stop during the test if they needed. The total time, the number of times it has stopped and the total distance traveled will be recorded. Oxygen saturation, heart rate, and blood pressure measurements will be taken before and after the test. According to the modified Borg scale, dyspnea, leg fatigue and general fatigue will be questioned.

Secondary Outcome Measures

  1. Waist circumference [Baseline]

    Waist circumference will be measured using a tape measure from the midpoint between the lowest rib and the iliac crest, when the patient is standing .

  2. Hip circumference [Baseline]

    Hip circumference will be measured parallel to the ground with a tape measure at the level of the trochanter major.

  3. Body fat percentage [Baseline]

    Body fat percentage will be analyzed with the BIA instrument (Tanita MC 780 MA Body Composition Analysis, Amsterdam, Netherlands).

  4. Body muscle percentage [Baseline]

    Body muscle percentage will be analyzed with the BIA instrument (Tanita MC 780 MA Body Composition Analysis, Amsterdam, Netherlands).

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Being in the 8-18 age range.

  • Being overweight (between 85 and 95 according to the Body Mass Index percentile).

  • Being obese (over 95 based on the Body Mass Index percentile).

  • Not doing any vigorous exercise two hours before the test.

Exclusion Criteria:
  • History of hospitalization in the last month for a reason that may affect physical performance.

  • Having neurological, musculoskeletal disease that prevents exercise tests.

  • Uncontrollable medical conditions (Cardiovascular, pulmonary disease, etc.).

  • Visual and/or vestibular disorders.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Istanbul University-Cerrahpasa Istanbul Turkey 34500

Sponsors and Collaborators

  • Istanbul University-Cerrahpasa

Investigators

  • Study Director: Goksen Kuran Aslan, PT, phD, Istanbul University-Cerrahpasa

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
nesrine benkhalifa, Principal Investigator, Istanbul University-Cerrahpasa
ClinicalTrials.gov Identifier:
NCT05392920
Other Study ID Numbers:
  • 2022/37
First Posted:
May 26, 2022
Last Update Posted:
Jul 8, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by nesrine benkhalifa, Principal Investigator, Istanbul University-Cerrahpasa
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 8, 2022